Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1565

1.

Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.

Yamada K, Goto S, Hamasaki T, Kuratsu JI.

Acta Neurochir (Wien). 2008 Jan;150(1):15-22; discussion 22. doi: 10.1007/s00701-007-1451-3. Epub 2008 Jan 10.

PMID:
18180867
2.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
3.

Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease.

Maurer C, Mergner T, Xie J, Faist M, Pollak P, Lücking CH.

Brain. 2003 May;126(Pt 5):1146-63.

PMID:
12690054
4.

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y.

Brain. 2002 Mar;125(Pt 3):575-83.

PMID:
11872614
5.

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP.

Arch Neurol. 2005 Apr;62(4):554-60.

PMID:
15824252
6.

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.

Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML.

Brain. 2009 Jan;132(Pt 1):172-84. doi: 10.1093/brain/awn294. Epub 2008 Nov 11.

PMID:
19001482
7.

Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.

Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS.

Mov Disord. 2009 Feb 15;24(3):329-35. doi: 10.1002/mds.22211.

PMID:
19006187
8.

Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.

Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY.

Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.

PMID:
19556833
9.

Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease - retrospective evaluation of postoperative independence in pursuing daily activities.

Yamada K, Hamasaki T, Kuratsu J.

Parkinsonism Relat Disord. 2009 Dec;15(10):746-51. doi: 10.1016/j.parkreldis.2009.05.004. Epub 2009 May 28.

PMID:
19481492
10.

Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.

Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, Ferrer E.

Arch Neurol. 2000 Jul;57(7):983-8.

PMID:
10891980
11.

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A.

Neurology. 1999 Jul 13;53(1):85-90.

PMID:
10408541
12.

Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.

Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.

Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.

PMID:
19174620
13.

Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.

Lyons KE, Davis JT, Pahwa R.

Stereotact Funct Neurosurg. 2007;85(4):169-74. Epub 2007 Jan 26.

PMID:
17259749
14.

Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.

Visser JE, Allum JH, Carpenter MG, Esselink RA, Limousin-Dowsey P, Honegger F, Borm GF, Bloem BR.

Neuroscience. 2008 Dec 10;157(4):798-812. doi: 10.1016/j.neuroscience.2008.09.051. Epub 2008 Oct 4.

PMID:
18952153
15.

Bilateral subthalamic nucleus stimulation for Parkinson's disease.

Doshi PK, Chhaya NA, Bhatt MA.

Neurol India. 2003 Mar;51(1):43-8.

16.

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E.

Mov Disord. 2007 May 15;22(7):990-7.

PMID:
17443692
17.

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.

Moro E, Esselink RJ, Benabid AL, Pollak P.

Brain. 2002 Nov;125(Pt 11):2408-17.

PMID:
12390968
18.

Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.

Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Ogawa K, Mizutani T.

J Neurosurg. 2001 Aug;95(2):213-21.

PMID:
11780890
19.
20.

Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.

Erola T, Heikkinen ER, Haapaniemi T, Tuominen J, Juolasmaa A, Myllylä VV.

Acta Neurochir (Wien). 2006 Apr;148(4):389-94. Epub 2005 Nov 14.

PMID:
16284705

Supplemental Content

Support Center